BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1672 related articles for article (PubMed ID: 19033641)

  • 1. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
    Weber DC; Trofimov AV; Delaney TF; Bortfeld T
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
    Baumert BG; Norton IA; Lomax AJ; Davis JB
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK; Fox T; Crocker I
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
    Milby AB; Both S; Ingram M; Lin LL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours.
    Petersen JB; Lassen Y; Hansen AT; Muren LP; Grau C; Høyer M
    Acta Oncol; 2011 Aug; 50(6):823-8. PubMed ID: 21767180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
    Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
    Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
    Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U; Bogner J; Georg D; Auberger T; Pötter R
    Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
    Palm A; Johansson KA
    Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
    Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
    Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
    Zhang P; Happersett L; Hunt M; Jackson A; Zelefsky M; Mageras G
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1456-62. PubMed ID: 19540062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons.
    MacDonald SM; Safai S; Trofimov A; Wolfgang J; Fullerton B; Yeap BY; Bortfeld T; Tarbell NJ; Yock T
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):979-86. PubMed ID: 18325681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking.
    Munck Af Rosenschöld P; Engelholm S; Ohlhues L; Law I; Vogelius I; Engelholm SA
    Acta Oncol; 2011 Aug; 50(6):777-83. PubMed ID: 21767174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of methods for beam angle optimization for IMRT using an accelerated exhaustive search strategy.
    Wang X; Zhang X; Dong L; Liu H; Wu Q; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1325-37. PubMed ID: 15519806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric verification of IMRT treatment planning using Monte Carlo simulations for prostate cancer.
    Yang J; Li J; Chen L; Price R; McNeeley S; Qin L; Wang L; Xiong W; Ma CM
    Phys Med Biol; 2005 Mar; 50(5):869-78. PubMed ID: 15798261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas.
    Kozak KR; Adams J; Krejcarek SJ; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):179-86. PubMed ID: 19019562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.